Horse chestnut seed extract

View my plan →

The short answer

Standardized aescin-containing extract can reduce chronic venous-insufficiency symptoms short term.

Evidence and scope: Supported for specific outcomes
This status does not grade the ingredient for every goal, outcome, or person.
Important limitation: Evidence supports a specific outcome, not a general wellness or longevity effect.
Before deciding: Key concern: Raw seed is toxic; anticoagulants, kidney/liver disease, diabetes, pregnancy, and surgery require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective

Venous symptoms100–150 mg/day aescin in divided doses

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source ↗

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFormulation-dependent

Not usefully classified as a fat- or water-soluble vitamin; absorption depends on the salt, extract, delivery system, and meal.

How it is commonly taken

Use only standardized, esculin-removed products.

Do not combine casually

Raw seed is toxic; anticoagulants, kidney/liver disease, diabetes, pregnancy, and surgery require review.

Dose and use source ↗

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger

1unique primary studies represented

—unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2012

Mixed or qualifiedPMID 23152216 · CD003230

Horse chestnut seed extract for chronic venous insufficiency

Short-term pain and leg-volume outcomes generally favored standardized extract, and adverse events were usually mild. The review still called for larger definitive trials; this is symptomatic evidence and does not establish prevention of ulcers, thrombosis, or long-term venous complications.

Published: 2012

Study design and methods

Design: Updated Cochrane systematic review of randomized controlled trials
Population: People with chronic venous insufficiency; six leg-volume trials included 502 participants, but the abstract did not report a complete review total
Intervention: Oral horse chestnut seed mono-extract versus placebo or reference therapy
Outcome: Leg pain, leg volume, edema-related symptoms, and adverse events

Funding or conflict note: The review reported no known conflicts of interest.

Open research record ↗

Unscreened discovery appendix—not evidence11 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

Official evidence overviewPubMed bounded human-evidence search Live PubMed discovery searchNational Library of Medicine

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.